See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate

Benzinga2021-08-31

AC Immune SA and its collaborating partner Genentech, part of Roche Holdings AG, have announced topline data from Phase 2 study evaluating semorinemab in mild-to-moderate Alzheimer's disease (AD). ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Jimmyboy
2021-08-31
Jimmyboy
Pls like and comment
ZhaoYingying
2021-08-31
ZhaoYingying
Like
benlauhh
2021-08-31
benlauhh
Please like! Thank you!
- ZhaoYingying:
  YE
- Vannies88:
  like
- yourself回复Vannies88:
  hey it is a lot of people
5121221c
2021-08-31
5121221c
X
KSONG
2021-08-31
KSONG
Like
LZH93
2021-08-31
LZH93
Like pls

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1138801141?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-31 20:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138801141","market":"us","top_or_hot":-1,"title":"See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate","media":"Benzinga","content":"<div>\n<p>AC Immune SA and its collaborating partner Genentech, part of Roche Holdings AG, have announced topline data from Phase 2 study evaluating semorinemab in mild-to-moderate Alzheimer's disease (AD).\n...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/08/22735879/see-why-ac-immune-stock-is-trading-higher-after-data-from-alzheimers-candidate\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSee Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 20:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/08/22735879/see-why-ac-immune-stock-is-trading-higher-after-data-from-alzheimers-candidate><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AC Immune SA and its collaborating partner Genentech, part of Roche Holdings AG, have announced topline data from Phase 2 study evaluating semorinemab in mild-to-moderate Alzheimer's disease (AD).\n...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/08/22735879/see-why-ac-immune-stock-is-trading-higher-after-data-from-alzheimers-candidate\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACIU","symbol_name":"AC Immune SA","start_time":0,"source_url":"https://www.benzinga.com/general/biotech/21/08/22735879/see-why-ac-immune-stock-is-trading-higher-after-data-from-alzheimers-candidate","article_id":"1138801141","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138801141","pubTimestamp":1630412925,"columns":[],"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"AC Immune SA and its collaborating partner Genentech, part of Roche Holdings AG, have announced topl","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACIU":"AC Immune SA","RHHBY":"罗氏控股"},"translate_title":"看看为什么AC免疫公司的股票在阿尔茨海默氏症候选人的数据后交易更高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACIU":0.9,"RHHBY":0.9},"content_text":"AC Immune SA and its collaborating partner Genentech, part of Roche Holdings AG, have announced topline data from Phase 2 study evaluating semorinemab in mild-to-moderate Alzheimer's disease (AD).\nSemorinemab met one of its co-primary endpoints, ADAS-Cog11 (cognitive scale). The second co-primary endpoint, ADCS-ADL (functional scale), was not met.\nSafety data showed that semorinemab was well tolerated with an acceptable safety profile and no unanticipated safety signals.\nSemorinemab demonstrated a statistically significant reduction in cognitive decline from baseline by 43.6% compared to placebo at week 49.\nThere was no effect on the other co-primary endpoint of reducing the rate of functional decline. Genentech has reported that the open-label portion of the study will continue as planned.\nFurther analyses are ongoing, and the company will submit topline data for presentation at the CTAD conference in November.\nSemorinemab is an investigational monoclonal anti-tau antibody that targets the N-terminal portion of the tau protein and is designed to bind to tau and slow its spread between neurons.\nPrice Action: ACIU shares are up 59.70% at $11.16 during the premarket session on the last check Tuesday.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":818282585,"gmtCreate":1630413925647,"gmtModify":1633678258306,"author":{"id":"3582072891665879","authorId":"3582072891665879","name":"Jimmyboy","avatar":"https://static.tigerbbs.com/cb9d5d497bceb3edaca216e9eeab3c22","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582072891665879","authorIdStr":"3582072891665879"},"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818282585","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":818280420,"gmtCreate":1630413423560,"gmtModify":1631893508786,"author":{"id":"3577155247763320","authorId":"3577155247763320","name":"ZhaoYingying","avatar":"https://static.tigerbbs.com/b86f603c032bb4185ad17dff4bc5cb95","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577155247763320","authorIdStr":"3577155247763320"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818280420","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":818280687,"gmtCreate":1630413321349,"gmtModify":1631891743468,"author":{"id":"3577336591268984","authorId":"3577336591268984","name":"benlauhh","avatar":"https://static.tigerbbs.com/3ee4a98f8cae9c1852df6f63da10a6ec","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577336591268984","authorIdStr":"3577336591268984"},"htmlText":"Please like! Thank you!&nbsp;","listText":"Please like! Thank you!&nbsp;","text":"Please like! Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/818280687","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5706037,"gmtCreate":1630413431423,"gmtModify":1635134746977,"authorId":3577155247763320,"author":{"id":3577155247763320,"idStr":"3577155247763320","authorId":3577155247763320,"name":"ZhaoYingying","avatar":"https://static.tigerbbs.com/b86f603c032bb4185ad17dff4bc5cb95","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":818280687,"type":1,"supId":0,"prevId":0,"content":"YE","text":"YE","html":"YE"},{"id":5706128,"gmtCreate":1630414149541,"gmtModify":1635134739250,"authorId":3582599354430550,"author":{"id":3582599354430550,"idStr":"3582599354430550","authorId":3582599354430550,"name":"Vannies88","avatar":"https://static.tigerbbs.com/d8dcb81eaca7e7ef6fd10117d992e0e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":818280687,"type":1,"supId":5706037,"prevId":0,"content":"like","text":"like","html":"like"},{"id":5706290,"gmtCreate":1630415862322,"gmtModify":1635134725693,"authorId":4089375229568220,"author":{"id":4089375229568220,"idStr":"4089375229568220","authorId":4089375229568220,"name":"yourself","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3582599354430550,"repliedAuthor":{"id":3582599354430550,"idStr":"3582599354430550","authorId":3582599354430550,"name":"Vannies88","avatar":"https://static.tigerbbs.com/d8dcb81eaca7e7ef6fd10117d992e0e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":818280687,"type":1,"supId":5706037,"prevId":5706128,"content":"hey it is a lot of people","text":"hey it is a lot of people","html":"hey it is a lot of people"}],"langContent":"EN"},{"id":818280145,"gmtCreate":1630413305987,"gmtModify":1631891774110,"author":{"id":"3549621931578219","authorId":"3549621931578219","name":"5121221c","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3549621931578219","authorIdStr":"3549621931578219"},"htmlText":"X","listText":"X","text":"X","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818280145","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":818217569,"gmtCreate":1630413252451,"gmtModify":1631892635563,"author":{"id":"3573608981633568","authorId":"3573608981633568","name":"KSONG","avatar":"https://static.tigerbbs.com/0cac42cab0c725d4b65ec3d804892fc9","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3573608981633568","authorIdStr":"3573608981633568"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818217569","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":818217953,"gmtCreate":1630413220472,"gmtModify":1631891116485,"author":{"id":"3561952980381559","authorId":"3561952980381559","name":"LZH93","avatar":"https://static.tigerbbs.com/dd274730798ffb61043997819bbeaa13","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3561952980381559","authorIdStr":"3561952980381559"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818217953","repostId":1138801141,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":41,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138801141"}